Cargando…

Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy

Apocrine carcinoma is a rare subtype of invasive ductal breast cancer that shows apocrine differentiation and largely triple-negative immunohistology. Triple-negative breast cancers are known to have more aggressive clinical courses. However, unlike most other subtypes, it is reported that triple-ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Taobo, Liu, Yiqiang, Wu, Jinbo, Hu, Xuejiao Lina, Zhao, Guiyang, Liang, Baosheng, Wang, Shu, Long, Mengping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949126/ https://www.ncbi.nlm.nih.gov/pubmed/35329934 http://dx.doi.org/10.3390/jcm11061607

Ejemplares similares

Intraparenchymal breast leiomyoma and atypical leiomyoma
por: Long, Mengping, et al.
Publicado: (2022)

Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
por: Long, Mengping, et al.
Publicado: (2022)

A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway Genes
por: Hu, Taobo, et al.
Publicado: (2021)

Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Yixi, et al.
Publicado: (2022)

Expression of DNA Helicase Genes Was Correlated with Homologous Recombination Deficiency in Breast Cancer
por: Long, Mengping, et al.
Publicado: (2022)

A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
por: Long, Mengping, et al.
Publicado: (2021)

Neoadjuvant targeted therapy for apocrine carcinoma of the breast: A case report
por: Yang, Ping, et al.
Publicado: (2020)

AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
por: Long, Mengping, et al.
Publicado: (2022)

Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
por: Hu, Taobo, et al.
Publicado: (2021)

Management of Metastatic Apocrine Hidradenocarcinoma with Chemotherapy and Radiation
por: Miller, Daniel H., et al.
Publicado: (2015)

Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy
por: Montagna, Emilia, et al.
Publicado: (2020)

The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database
por: Wu, Jinbo, et al.
Publicado: (2022)

Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan
por: Song, Qianqian, et al.
Publicado: (2022)

Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions
por: Kubouchi, Koichi, et al.
Publicado: (2020)

A rare presentation of triple-negative apocrine breast carcinoma with metastases
por: Bedford, Tyler, et al.
Publicado: (2014)

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer
por: Kim, Ji-Yeon, et al.
Publicado: (2023)

Tripartite genome of all species
por: Long, MengPing, et al.
Publicado: (2016)

Prognosis in triple‐negative apocrine carcinomas of the breast: A population‐based study
por: Wu, Wenyu, et al.
Publicado: (2019)

Apocrine Hidrocystoma of the Cheek
por: Lee, Myung Jun, et al.
Publicado: (2012)

Apocrine Adenocarcinoma of the Vulva
por: Kajal, Babita, et al.
Publicado: (2013)

Apocrine lesions of the breast
por: Quinn, Cecily M., et al.
Publicado: (2021)

Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes
por: Bonnefoi, Hervé, et al.
Publicado: (2019)

Clinicopathological Characteristics and Prognosis of Triple-Negative Apocrine Carcinoma: A Case-Control Study
por: Suzuki, Chiho, et al.
Publicado: (2023)

Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy
por: Hu, Taobo, et al.
Publicado: (2021)

Tumor-associated macrophages are associated with response to neoadjuvant chemotherapy and poor outcomes in patients with triple-negative breast cancer
por: Ye, Jia-hui, et al.
Publicado: (2021)

Primary Cutaneous Apocrine Carcinoma
por: Loh, Seung-Hee, et al.
Publicado: (2016)

Orbital apocrine hidrocystoma with ptosis
por: Huang, Vincent, et al.
Publicado: (2022)

Is adjuvant chemotherapy better than neoadjuvant chemotherapy for those with node positive disease?
por: Zabell, Joseph, et al.
Publicado: (2018)

CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy
por: Tokunaga, Eriko, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study
por: Shao, Zhiying, et al.
Publicado: (2016)

Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Wong, Willard, et al.
Publicado: (2021)

FABP7 and HMGCS2 Are Novel Protein Markers for Apocrine Differentiation Categorizing Apocrine Carcinoma of the Breast
por: Gromov, Pavel, et al.
Publicado: (2014)

Poorly differentiated cutaneous apocrine carcinomas: histopathological clues and immunohistochemical analysis for the diagnosis of this unusual neoplasm
por: Plaza, Jose A, et al.
Publicado: (2022)

TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer
por: Cabioglu, Neslihan, et al.
Publicado: (2021)

Primary Cutaneous Cribriform Apocrine Carcinoma
por: Boettler, Michelle, et al.
Publicado: (2021)

The Role of Carboplatin in the Neoadjuvant Chemotherapy Treatment of Triple Negative Breast Cancer
por: Castrellon, Aurelio Bartolome, et al.
Publicado: (2017)

Immune responses during neoadjuvant chemotherapy in triple negative breast cancer
por: Ghallab, Ahmed
Publicado: (2020)

Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
por: Ding, Feng, et al.
Publicado: (2022)

The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: Johnson, Kai Conrad Cecil, et al.
Publicado: (2023)

Defining Key Genes Regulating Morphogenesis of Apocrine Sweat Gland in Sheepskin
por: Li, Shaomei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uejoblmacsi6p46tdnmruvg0be